Strategies Targeting Telomerase Inhibition
- 28 October 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Biotechnology
- Vol. 41 (2), 194-199
- https://doi.org/10.1007/s12033-008-9117-9
Abstract
Telomerase plays a pivotal role in cellular immortality and tumorigenesis. Its activity is normally not detectable in most somatic cells while it is reactivated in the vast majority of cancer cells. Therefore, inhibition of telomerase has been viewed as a promising anticancer approach due to its specificity for cancer cells. Studies so far have shown that telomerase inhibition can inhibit the proliferation of cancer cells or cause apoptosis while it has no effect on most normal cells. Strategies currently being applied to induce telomerase inhibition target virtually all of the major components of the ribonucleoprotein holoenzyme and related cell signal pathways that regulate its activity. These strategies include inhibition of telomerase through targeting at the telomerase reverse transcriptase (TERT) catalytic subunit, the telomerase RNA (TR) component, and associated proteins. Other strategies have been developed to target the proteins associated with telomerase at the telomeric ends of chromosomes such as tankyrase. The specific mechanisms that mediate those inhibition effects include small molecules, antisense RNA, and ribozymes. Although the beneficial evidence of telomerase inhibition is obvious, limitations of strategies remain to be resolved to increase the feasibility of clinical application. This analysis will summarize recent developments of strategies in telomerase inhibition.Keywords
This publication has 26 references indexed in Scilit:
- Screening of Telomerase InhibitorsMethods in molecular biology (Clifton, N.J.), 2007
- RNA Interference: Biology, Mechanism, and ApplicationsMicrobiology and Molecular Biology Reviews, 2003
- Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.2003
- Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathwaysOncogene, 2003
- Analysis of telomerase activity and detection of its catalytic subunit, hTERTAnalytical Biochemistry, 2003
- Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for CancerJournal of the American Geriatrics Society, 2003
- Telomeres and Telomerase: Basic Science Implications for AgingJournal of the American Geriatrics Society, 2001
- Inhibition of Human Telomerase by 7-Deaza-2′-deoxyguanosine Nucleoside Triphosphate Analogs: Potent Inhibition by 6-Thio-7-deaza-2′-deoxyguanosine 5′-TriphosphateBioorganic Chemistry, 2001
- Molecular mechanisms of action of antisense drugsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997